Sky News Australia: Clinical trials show Hydroxychloroquine is ‘safe’ with no reported toxicity.
Concerned Ontario Doctors President Dr Kulvinder Kaur Gill says contrary to the media narrative, potential COVID-19 treatment Hydroxychloroquine is a “safe and generic medication” approved 65 years ago which is sold over the counter.
Dr Gill pointed out while Hydroxychloroquine as been criminalised in some Australian states, it has been clearly listed on the World Health Organisation’s page of essential medications for an extended period of time.
“When used in the appropriate dose, there has been no reported cardiac toxicity in all the clinical trials and studies done in COVID-19 patients to date,” she said.
“A study published recently in the Journal of Electrocardiology found no clinically significant changes in the non-ICU COVID-19 patients when they were treated with a five-day Azithromycin-Hydroxychloroquine combo”.
She also highlighted a “peer reviewed systematic publication that actually showed that HCQ is protective to the heart as opposed to being harmful”.
The intervention of government into the medical sector which has made the use of hydroxychloroquine unlawful in some developed countries is unprecedented and reveals how politicised the pandemic has become, Dr Gill said.
“Doctors have always had the ability to prescribe existing approved medications for non-indicative conditions”.
https://youtu.be/VIJj_7Cno-w Days after the election, Van Jones went on CNN and revealed something most…
https://youtu.be/kj3DV0ntXlU On this episode of “The Liz Wheeler Show,” Liz Wheeler exposes the bombshell…
https://youtu.be/OKFx85sCN9U The image that's been forwarded around church for twenty years, a protein shaped…
https://youtu.be/5fyPOpSfLMY Seven ways to store and treat drinking water when the taps stop, from…
https://www.youtube.com/watch?v=uvfI7Qj_iYU It is fascinating when we read the Book of Genesis to hear about…
https://youtu.be/4WVEGIiO-SY Was Peter the first pope? The Bible contradicts such a foolish idea. Never…
This website uses cookies.